INTRODUCTION
Chronic liver diseases and their complications constitute a major health problem all over the world and especially in our country [1] . Most of the morbidity and mortality of chronic liver diseases is due to its progression and complications of cirrhosis [2] . Ascites is a frequent complication of advanced liver cirrhosis. Over 50% of cirrhotic patients develop ascites due to increased sodium retention in the kidneys, leading to expansion of extracellular volume and accumulation of fluid in the peritoneum [3] . The cancer antigen (CA) -125 is a high molecular mass glycoprotein produced both by ovarian cancer epithelial cells and mesothelial cells [4] .
Serum CA-125 levels are used as a marker of tumour activity in patients known to have ovarian carcinoma [5] , the severity of liver disease evaluated by MELD score and the presence of ascites were significantly correlated with the elevation of CA-125 level [6] . Serum CA-125 levels are generally found to be higher in malignant conditions compared to benign conditions. Levels exceeding 1000 U/ml have been described in benign conditions associated with massive pleural effusion and ascites [7] . As no enough Egyptian studies were done on the validity of CA-125 and chronic liver diseases or HCC patients, so we aimed to assess the serum and/or ascitic fluid level of CA125 in post HCV cirrhotic patients (decompensated or not) with or without HCC. Serum and ascetic fluid level of CA-125 were assessed and measured: Specimen collection and preparation: 5ml of venous blood as well as an ascitic sample were taken under complete aseptic conditions. Instrument: The Roche diagnostics cobas e 411 analyzer was used. Steps of test: Sandwich principle, total duration of assay: 18 minutes. Normal range of CA125 serum level: up to 21 u/ml, Ascitic fluid level: up to 35 u/ml [13] .
PATIENTS AND METHODS

Statistical analysis
IBM SPSS statistics (V. 19.0, IBM Corp., USA, 2010) was used for data analysis. Data were expressed as Mean ± SD for quantitative parametric measures in addition to Median Percentiles for quantitative non-parametric measures and both number and percentage for categorized data.
The following tests were done: (1) Comparison between two independent groups for non-parametric data using Wilcoxon Rank Sum test. (2) Ranked Sperman correlation test to study the possible association between each two variables among each group for non-parameteric data. (3) Chisquare test to study the association between each 2 variables or comparison between 2 independent groups as regards the categorized data. The probability of error at 0.05 was considered sig., while at 0.01 was considered highly sig. (4) The ROC was constructed to evaluate the most discriminating markers between the compared groups, AUC can also be calculated.
RESULTS
In order to fulfill our aim, (120) cases were included and divided into two groups; Group I: In Table ( reported a positive correlation between serum and ascitic fluid levels of CA-125, however ascitic fluid levels were higher than serum levels, which explained that the antigen is mesothelial rather than tumoral origin. However our results reported that the ascitic level of Ca 125 was elevated in decompensated HCC group (D) than non HCC group (B), this supported that the antigen origin may be from both mesothelial and tumoral cells.
Regarding the correlation between AFP and CA125 serum and ascitic level; Only AFP had significant diagnostic performance in differentiating compensated and decompensated HCC groups (C) & (D) from non-HCC groups (A) &(B). However Lopez et al. [19] who stated that AFP-CA-125 combination had the highest sensitivity to diagnose 96% of the HCC patients, also both could be combined for HCC screening due to their excellent sensitivity and specificity, respectively: a negative result for both, or even CA 125 alone, would discourage HCC diagnosis, while positive results of both would make HCC presence highly probable. A positive CA 125 and negative AFP would be equivocal for HCC. Also Elias and Kew [20] reported that CA 125 has a highly sensitivity but lacks specificity for HCC diagnosis.
